Athersys, Inc. (ATHXQ)

Market Cap	62.00 -100.0%
Revenue (ttm)	80.00K -98.7%
Net Income	-37.51M
EPS	-1.89
Shares Out	61.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,565
Average Volume	8,608
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	n/a
Beta	50.90
RSI	66.95
Earnings Date	n/a

About Athersys

Athersys, Inc., a clinical-stage biotechnology company, develops therapies in the regenerative medicine area. Its stem cell product candidate is the MultiStem cell therapy, an allogeneic stem cell product for the treatment of indications in the neurological, inflammatory and immune, and cardiovascular disease areas, as well as other critical care conditions. The company was founded in 1995 and is headquartered in Cleveland, Ohio. On September 24, 2024, the voluntary petition of Athersys, Inc. for reorganization under Chapter 11 was converted to...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: ATHXQ